Donor lymfocyte infusions for relapsed multiple myeloma after allogeneic stem-cell transplantation: predictive factors for response and long-term outcome.

H.M. Lokhorst, A. Schattenberg, J.J. Cornelissen, M.H.J. van Oers, W.E. Fibbe, I.M.B. Kampschoer-Russel, N.W.C.J. van de Donk, L.F. Verdonck

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)3031-3037
Number of pages7
JournalJournal of Clinical Oncology
Volume18
Publication statusPublished - 2000

Cite this